247 results
Page 7 of 13
8-K
EX-99.1
7m7l546cd
11 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
2wtfjvr5
8 Aug 11
Ligand Pharmaceuticals Announces Second Quarter Results
12:00am
8-K
EX-99.1
2oby d51f
26 Jul 11
Ligand Partner GlaxoSmithKline Receives Positive Data from Promacta® PIII
12:00am
8-K
EX-99.1
cloub0
22 Jun 11
Product has Potential to Offer Important Advantages Over Current IV Melphalan
12:00am
8-K
EX-99.1
qq4a0 2or
20 Jun 11
Rob McKay, Sr. Dir. Business Development
12:00am
8-K
EX-99.1
ck16m64
10 May 11
Ligand Pharmaceuticals Reports First Quarter Results
12:00am
8-K
EX-99.1
3eft5ec4zsyk8gnjjea
18 Apr 11
Ligand Names Matthew W. Foehr Chief Operating Officer
12:00am
8-K
i8m18r2rfy8
18 Apr 11
Ligand Names Matthew W. Foehr Chief Operating Officer
12:00am
8-K
EX-99.1
cvrjl zf90b
15 Feb 11
Ligand Announces Fourth Quarter and Full Year 2010 Consolidated Financial Results
12:00am
8-K
EX-99.1
z9352tak
9 Feb 11
Ligand Appoints John L. LaMattina to Board of Directors
12:00am
8-K
EX-99.1
gqg3x3qt81via md
31 Jan 11
Ligand Forms Strategic Drug Development Alliance with Chiva Pharmaceuticals
12:00am
8-K
EX-99.1
f5vfe1j ev
7 Oct 10
Regulation FD Disclosure
12:00am
8-K
kpyn3i22sz1yf3kpm
3 May 10
Entry into a Material Definitive Agreement
12:00am